Old Web
English
Sign In
Acemap
>
authorDetail
>
Tomohiro Onoue
Tomohiro Onoue
GlaxoSmithKline
Anemia
Medicine
Intensive care medicine
Hemodialysis
Darbepoetin alfa
4
Papers
46
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Single-Dose, Open-Label, Randomized, Two-Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat.
2020
Clinical pharmacology in drug development
Masanori Yamada
Minori Osamura
Hirofumi Ogura
Tomohiro Onoue
Akira Wakamatsu
Yotaro Numachi
Stephen Caltabiano
Kelly M. Mahar
Show All
Source
Cite
Save
Citations (1)
Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia: A Randomized, Double-Blind, Phase 3 Trial
2020
Clinical Journal of The American Society of Nephrology
Tadao Akizawa
Masaomi Nangaku
Taeko Yonekawa
Nobuhiko Okuda
Shinya Kawamatsu
Tomohiro Onoue
Yukihiro Endo
Katsutoshi Hara
Alexander R. Cobitz
Show All
Source
Cite
Save
Citations (23)
SaO036Efficacy and safety of daprodustat compared with darbepoetin alfa in Japanese hemodialysis patients with anemia: a randomized, double-blind, phase 3 trial
2019
Nephrology Dialysis Transplantation
Tadao Akizawa
Masaomi Nangaku
Taeko Yonekawa
Nobuhiko Okuda
Shinya Kawamatsu
Tomohiro Onoue
Yukihiro Endo
Katsutoshi Hara
Hirofumi Ozeki
Alexander R. Cobitz
Show All
Source
Cite
Save
Citations (2)
A 24‐week Anemia Correction Study of Daprodustat in Japanese Dialysis Patients
2019
Therapeutic Apheresis and Dialysis
Yoshiharu Tsubakihara
Tadao Akizawa
Masaomi Nangaku
Tomohiro Onoue
Taeko Yonekawa
Hideki Matsushita
Yukihiro Endo
Alexander R. Cobitz
Show All
Source
Cite
Save
Citations (20)
1